ImmuCell Corp (NASDAQ: ICCC) stock suffered a major decline of -10.6% on 4/8/25. The shares closed at $4.81. Moreover, exceptionally high trading volume at 316% of normal accompanied the decline. The stock has been exceptionally strong relative to the market over the last nine months and is unchanged during the last week.
Current PriceTarget Research Rating
ImmuCell has a current Value Trend Rating of C (Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. ImmuCell has a very low Appreciation Score of 13 but a very high Power Rating of 86, and the Neutral Value Trend Rating results.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment